BE826498A - Composition therapeutique solide a usage interne - Google Patents

Composition therapeutique solide a usage interne

Info

Publication number
BE826498A
BE826498A BE154189A BE154189A BE826498A BE 826498 A BE826498 A BE 826498A BE 154189 A BE154189 A BE 154189A BE 154189 A BE154189 A BE 154189A BE 826498 A BE826498 A BE 826498A
Authority
BE
Belgium
Prior art keywords
therapeutic composition
internal use
solid therapeutic
solid
internal
Prior art date
Application number
BE154189A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE826498A publication Critical patent/BE826498A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
BE154189A 1974-03-12 1975-03-10 Composition therapeutique solide a usage interne BE826498A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (fr) 1974-03-12 1974-03-12

Publications (1)

Publication Number Publication Date
BE826498A true BE826498A (fr) 1975-06-30

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
BE154189A BE826498A (fr) 1974-03-12 1975-03-10 Composition therapeutique solide a usage interne

Country Status (12)

Country Link
US (1) US3976764A (fr)
JP (1) JPS5512411B2 (fr)
BE (1) BE826498A (fr)
CA (1) CA1054056A (fr)
CH (1) CH604719A5 (fr)
DE (1) DE2510620C2 (fr)
DK (1) DK142802B (fr)
ES (1) ES435500A1 (fr)
FR (1) FR2263744B1 (fr)
GB (1) GB1507521A (fr)
NL (1) NL7502952A (fr)
SE (1) SE409286B (fr)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
DE3278491D1 (en) * 1981-07-15 1988-06-23 Key Pharma Sustained release theophyline
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS5953410A (ja) * 1982-09-20 1984-03-28 Fujisawa Pharmaceut Co Ltd 新型ソフトカプセル剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
JPS61107782U (fr) * 1984-12-19 1986-07-08
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
EP0536277A1 (fr) * 1990-06-25 1993-04-14 The Du Pont Merck Pharmaceutical Company Suspension d'hydrochlorure d'amantadine possedant des caracteristiques de dissolution ameliorees, utilisee dans la preparation de capsules de gelatine souples
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
KR100620935B1 (ko) 1998-03-19 2006-09-13 브리스톨-마이어스스퀴브컴파니 용해도가 높은 약물에 대한 2상 서방성 전달 시스템과 방법
EP1245227A1 (fr) * 2001-03-31 2002-10-02 Jagotec Ag Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
BRPI0407438A (pt) * 2003-02-21 2006-02-07 Lek Pharmaceuticals Sistema terapêutico compreendendo amoxicilina e ácido clavulânico
WO2005046655A1 (fr) * 2003-11-04 2005-05-26 Shire Laboratories, Inc. Liberation prolongee de molecules actives d'un point de vue pharmacologique positivement chargees a partir d'une matrice contenant des polymeres avec des atomes d'oxygene polarises
RU2420268C2 (ru) * 2006-09-04 2011-06-10 Панацея Биотек Лимитед Способ программируемой плавучей доставки
WO2009087665A2 (fr) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Nouveau système d'administration de médicament à rétention gastrique
GB2462022B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
EP2329810A4 (fr) * 2008-08-18 2012-09-19 Team Academy Of Pharmaceutical Science Système d'administration de médicament à rétention gastrique, procédé de préparation et son utilisation
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
EP2457561A4 (fr) * 2009-07-06 2014-03-05 Kyorin Seiyaku Kk Comprimé ayant une structure creuse
US9314430B2 (en) 2010-07-05 2016-04-19 Jagotec Ag Floating gastric retentive dosage form
US20140234409A1 (en) * 2011-07-14 2014-08-21 APET Holding B.V. Nicotinamide compositions and the therapeutic use thereof
AU2012322323B2 (en) 2011-10-11 2016-04-21 Sun Pharmaceutical Industries Limited A gastroretentive dosage system and process of preparation thereof
EP2872140A1 (fr) * 2012-07-16 2015-05-20 APeT Holding B.V. Système d'administration pharmacologique à rétention gastrique
HUE025008T2 (en) 2012-10-12 2016-04-28 Omya Int Ag Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
SG10201912100SA (en) 2014-06-11 2020-02-27 Massachusetts Inst Technology Residence structures and related methods
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
EP3034070A1 (fr) 2014-12-18 2016-06-22 Omya International AG Procédé pour la production d'un système d'administration pharmaceutique
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
EP3069713A1 (fr) 2015-03-20 2016-09-21 Omya International AG Forme posologique dispersible
CA2983272C (fr) 2015-05-01 2023-08-29 Massachusetts Institute Of Technology Dispositifs d'induction a memoire de forme pouvant etre declenches
WO2017070612A1 (fr) 2015-10-23 2017-04-27 Lyndra, Inc. Systèmes à demeure gastriques pour libération prolongée d'agents thérapeutiques et leurs procédés d'utilisation
CA3007633A1 (fr) 2015-12-08 2017-06-15 Lyndra, Inc. Configurations geometriques de systemes a residence gastrique
EP3429556A1 (fr) * 2016-03-18 2019-01-23 Grünenthal GmbH Forme pharmaceutique flottante
EP3269361A1 (fr) 2016-07-14 2018-01-17 Omya International AG Forme posologique
WO2018064630A1 (fr) 2016-09-30 2018-04-05 Lyndra, Inc. Systèmes de résidence gastrique permettant l'administration prolongée de médicaments de la classe de l'adamantane
WO2023166225A1 (fr) * 2022-03-04 2023-09-07 APET Holding B.V. Formulations d'enzyme digestive

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Also Published As

Publication number Publication date
DE2510620A1 (de) 1975-09-18
DK142802C (fr) 1981-09-21
DK142802B (da) 1981-02-02
GB1507521A (en) 1978-04-19
NL7502952A (nl) 1975-09-16
JPS50121418A (fr) 1975-09-23
SE409286B (sv) 1979-08-13
DE2510620C2 (de) 1984-01-05
FR2263744B1 (fr) 1978-11-24
ES435500A1 (es) 1977-02-01
SE7502725L (fr) 1975-09-13
DK97875A (fr) 1975-09-13
US3976764A (en) 1976-08-24
CA1054056A (fr) 1979-05-08
FR2263744A1 (fr) 1975-10-10
JPS5512411B2 (fr) 1980-04-02
CH604719A5 (fr) 1978-09-15

Similar Documents

Publication Publication Date Title
BE826498A (fr) Composition therapeutique solide a usage interne
BE830343R (fr) Garnitures absorbantes a jeter apres usage
ATA591176A (de) Zahnfullmasse
FR2315985A1 (fr) Melangeur rotatif interne
IT1031876B (it) Perfezionamenti relative a meccanismi di trasmissione
SE7511711L (sv) Roterande forbrenningsmotor
DK268875A (da) Akkumulator med viklede elektroder
BE855919Q (fr) Sel de lysine a action therapeutique
SE7506076L (sv) Rotationsmotor
BR7505101A (pt) Pilha a combustivel aperfeicoada
IT1043192B (it) Pila a combustibile perfezionata
FR2291737A1 (fr) Compresse a usage medical
ZA756928B (en) Rotary piston engine
FR2288718A1 (fr) Composition refractaire a durcissement rapide
FR2284043A1 (fr) Carburateur a starter perfectionne
BE833906A (fr) Compositions pharmaceutiques comprenant des canadensolides propres a la guerison des ulceres
BE826797A (fr) Perfectionnements relatifs a des trepans
IT1040438B (it) Perfezionamenti relativi a composizioni leganti
FR2281230A1 (fr) Duplicateur rotatif
FR2290165A1 (fr) Composition a fumer
ZA753285B (en) Angular position transducers for use in engine timing controls
IT1042443B (it) Fresetta per dentisti
ZA752041B (en) Improvements relating to pharmaceutical compositions with an antiulcus activity
CU34348A (es) Composicion terapeutica
BE820235A (fr) Composition therapeutique a injecter

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: EISAI CO. LTD

Effective date: 19930331